Lateral sphincterotomy diminishes internal anal sphincter hypertonia and th
ereby reduces anal canal pressure. This improves anal mucosal blood flow an
d promotes the healing of anal fissures. However, sphincterotomy can be ass
ociated with long term disturbances of sphincter function. The optimal trea
tment for an anal fissure is to induce a temporary reduction of anal canal
resting pressure to allow healing of the fissure without permanently disrup
ting normal sphincter function. Broader understanding of the intrinsic mech
anisms controlling smooth muscle contraction has allowed pharmacological ma
nipulation of anal sphincter tone. We performed an initial Medline literatu
re search to identify all articles concerning "internal anal sphincter" and
"anal fissures". This review is based on these articles and on additional
publications obtained by manual cross referencing. Internal anal smooth mus
cle relaxation can be inhibited by stimulation of nonadrenergic non-choline
rgic enteric neurones, parasympathetic muscarinic receptors, or sympathetic
beta adrenoceptors, and by inhibition of calcium entry into the cell. Sphi
ncter contraction depends on an increase in cytoplasmic calcium and is enha
nced by sympathetic alpha adrenergic stimulation. Currently, the most commo
nly used pharmacological agent in the treatment of anal fissures is topical
glyceryl trinitrate, a nitric oxide donor. Alternative agents that exhibit
a similar effect via membrane Ca2+ channels, muscarinic receptors, and alp
ha or beta adrenoceptors are also likely to have a therapeutic potential in
treating anal fissures.